Pharma-Bio Serv, Inc. (PBSV)

Market Cap	16.07M
Revenue (ttm)	15.12M
Net Income (ttm)	613,029
Shares Out	22.96M
EPS (ttm)	0.03
PE Ratio	26.32
Forward PE	6.24
Dividend	$0.08 (10.71%)
Ex-Dividend Date	Jan 29, 2024

Volume	180
Open	0.700
Previous Close	0.700
Day's Range	0.700 - 0.700
52-Week Range	0.650 - 1.100
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 30, 2023

About PBSV

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered ...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1993
• Employees: 100
• Stock Exchange: OTCMKTS
• Ticker Symbol: PBSV

Financial Performance

In 2023, PBSV's revenue was $16.98 million, a decrease of -12.48% compared to the previous year's $19.40 million. Earnings were $1.31 million, an increase of 30.15%.